How a routine pap smear ends up costing $1,000

October 16, 2013 by Brenda Goodman, Healthday Reporter
How a routine pap smear ends up costing $1,000
Family physician investigated how some of her patients received big bills for common tests.

(HealthDay)—When doctors think about tests that might cause sticker shock for their patients, they wouldn't normally consider a simple Pap smear.

Pap smears are routine tests that use to screen for signs of cervical cancer. Before they were widely adopted in the late 1950s, the disease was a leading cancer killer of women. According to the U.S. National Institutes of Health, Pap testing has helped curb deaths by more than 60 percent.

To perform a Pap test, a doctor swabs some cells from a woman's cervix and sends them to a lab, where they're examined under a microscope by a pathologist. The cost for that service is normally between $20 and $30.

So Dr. Cheryl Bettigole, a family physician in Millville, N.J., was initially caught off guard when some of her patients called to complain that their bills for their Pap smears were hundreds of dollars more than she, or they, had expected.

Not anymore. "These days," she wrote in an article published in the Oct. 17 issue of the New England Journal of Medicine, "I am no longer surprised to find laboratory charges of $1,000 or more."

"The doctor's office is the only place I know of where we tolerate this lack of transparency," Bettigole said in an interview. "You don't go buy shoes and say, 'I wonder how much they're going to cost when I look at my Visa bill.' "

"It has a really serious impact on people," she said. "I've had patients turn down all sorts of testing or they won't go to the hospital if they need to go because they're afraid of the bill they're going to get."

Why have bills for such a routine test suddenly spiked? Bettigole did some checking. She found out that it's not the Pap test itself that's usually the big-ticket item. For women who have insurance, Pap tests involve no out-of-pocket costs to patients under the Affordable Care Act.

Instead, she said, it is other tests that laboratories have promoted to doctors along with Pap smears that drive up the price. For example, many labs offer to check for sexually transmitted diseases such as chlamydia and gonorrhea along with a Pap smear. They will also look for the Trichomonas parasite or specifically identify the exact species of found in a sample.

Although there are certainly some cases in which it would make sense to test for those kinds of infections, Bettigole said it's not appropriate to check for them in every case.

"There's no real reason why we need to identify a strain of yeast," she said. "You can diagnose yeast by looking under the microscope. If you see yeast, you treat yeast. I don't need to know what strain. But labs will often charge a huge rate for telling me that."

And Bettigole said it's all too easy to check the box for one of the combination tests on an order form, instead of a plain Pap. She said most doctors have no idea how much all those tests can inflate the tab and harm patients.

A large part of the problem is that labs don't charge set prices for their tests. They typically charge their highest rates to uninsured patients and lower rates to patients who have insurance companies negotiating on their behalf. And even prices for insured patients vary by insurance company, one expert said.

"Oftentimes, their negotiated contracts with rates vary between insurers, so there's not simply one price per test," said Scott McGoohan, vice president of reimbursement and scientific affairs for the American Clinical Laboratory Association.

That makes it difficult for doctors and patients to find out ahead of time what a is going to cost.

Still, McGoohan said, laboratories don't deserve the blame when bills creep up.

"Laboratories don't order the tests they perform. We are a third-party contractor who is hired to do a service," he said. "As the article itself indicates, a large part of the responsibility lies at the physician's pen and what they choose to order."

For its part, the American Congress of Obstetricians and Gynecologists (ACOG) said it's working to make sure doctors are better educated about the tests they order.

"ACOG is concerned when we become aware of excessive health care charges, particularly to a vulnerable public," the organization said in a statement about Bettigole's article. "ACOG is working hard to develop educational resources for our fellows and residents-in-training to increase awareness about the costs and appropriateness of many interventions, including diagnostic tests."

Explore further: Pap, HPV testing unnecessarily high in under-21-year-olds

More information: For more about cervical cancer screening, head to the U.S. Centers for Disease Control and Prevention.

Related Stories

Pap, HPV testing unnecessarily high in under-21-year-olds

September 23, 2013
(HealthDay)—For women younger than 21 years, Papanicolaou (Pap) and human papillomavirus (HPV) testing are unnecessarily high, according to a study published in the September issue of the American Journal of Obstetrics ...

Research makes connetion between tubal ligation and increase in cervical cancer rates

January 14, 2013
the surgical tying or severing of fallopian tubes to prohibit pregnancy – have less frequent Pap smears, which puts them at an increased risk for cervical cancer, according to research recently released by a team that included ...

Doctors too pap-happy, survey suggests

April 8, 2013
(HealthDay)—Most primary care physicians advise women to get "Pap" tests for cervical cancer screening more often than clinical guidelines recommend, new research reveals.

Less frequent pap tests safe for most women, ob/gyn group says

October 22, 2012
(HealthDay)—Most women need testing for cervical cancer only every three to five years, rather than annually, according to the American College of Obstetricians and Gynecologists.

Younger women start to follow pap test guidelines: CDC

January 3, 2013
(HealthDay)—More young women are following recently revised U.S. guidelines for getting Pap tests—the standard screening for cervical cancer—but many women who have had a total hysterectomy still get the tests unnecessarily, ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.